NCT06880055View on ClinicalTrials.gov

Shield Post-Approval Study Protocol

RecruitingOBSERVATIONAL
Enrollment

3,375

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

December 1, 2030

Conditions
Colo-rectal Cancer
Interventions
DIAGNOSTIC_TEST

Shield Blood Test for colo-rectal cancer Screening

Shield Blood Test for colo-rectal cancer Screening

Trial Locations (1)

61822

RECRUITING

Christie Clinic, Champaign

Sponsors
All Listed Sponsors
lead

Guardant Health, Inc.

INDUSTRY